NDC 71288-019

Tigecycline

Tigecycline

Tigecycline is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Tigecycline.

Product ID71288-019_f09be967-0036-46c3-9766-005ed39d15c8
NDC71288-019
Product TypeHuman Prescription Drug
Proprietary NameTigecycline
Generic NameTigecycline
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-05-13
Marketing CategoryANDA /
Application NumberANDA214020
Labeler NameMeitheal Pharmaceuticals Inc.
Substance NameTIGECYCLINE
Active Ingredient Strength50 mg/5mL
Pharm ClassesTetracycline-class Antibacterial [EPC],Tetracyclines [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 71288-019-11

10 VIAL, SINGLE-DOSE in 1 CARTON (71288-019-11) > 5 mL in 1 VIAL, SINGLE-DOSE (71288-019-10)
Marketing Start Date2021-05-13
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tigecycline" or generic name "Tigecycline"

NDCBrand NameGeneric Name
0781-3481TigecyclineTigecycline
16729-364TIGECYCLINETIGECYCLINE
55150-228TigecyclineTigecycline
60505-6098TigecyclineTIGECYCLINE
63323-960TigecyclineTigecycline
70121-1647TigecyclineTigecycline
70594-035TigecyclineTigecycline
71288-019TigecyclineTigecycline
0008-4990TygacilTIGECYCLINE
0008-4994TygacilTIGECYCLINE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.